Completed Cancer NIHR-supported project Digestion, Kidneys & Other Organs
A Phase 1 Randomised, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Activity of Allogeneic Alternatively Activated Macrophages (AAM) in Patients with Paracetamol-induced Acute Liver Injury
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by NIHR.
Researchers
Simon Hill (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
A Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of GSK4532990 in Adults with Alcohol-related Liver Disease (ALD)
ALG-020572-401: A Phase 1, Double-Blind, Randomized, Placebo-Controlled, First-in-Human Study of Subcutaneously Administered ALG-020572 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Ascending Doses in Healthy Volunteers (Part 1) and Multiple Doses in Subjects with Chronic Hepatitis B (Part 2)
An Open-label Phase 1/2 Multicentre Study to Evaluate the Safety, Tolerability, and Efficacy of RTX001 Autologous Macrophages in Participants with Liver Cirrhosis who have Hepatic Decompensation (EMERALD)
Macrophage Therapy for Acute Liver Failure
A phase 1/2 dose-exploration and dose-expansion study to evaluate the safety and efficacy of beam-302 in adult patients with alpha-1 antitrypsin deficiency (aatd)-associated lung disease and/or liver disease
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know